triazolam has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H | 1 |
| Haramoto, T | 1 |
| Sasaki, T | 1 |
| Hironaka, K | 1 |
| Shikata, K | 1 |
| Takahashi, K | 1 |
| Ota, Z | 1 |
1 other study available for triazolam and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Massive eosinophilic infiltration in a patient with the nephrotic syndrome and drug-induced interstitial nephritis.
Topics: Eosinophilia; Eosinophils; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; M | 1995 |